In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best Fortune 500 dividend stocks to buy right now. Compiled and published by Fortune ...

CVS Health Corp. closed 34.84% short of its 52-week high of $80.75, which the company achieved on March 28th.

By CVS allegedly ignoring evidence and violating both the Controlled Substances Act (CSA) and False Claims Act (FCA), the pharmacy reached corporate-mandated performance metrics, received ...

CVS corporate allegedly fueled the practice by pushing performance metrics, incentive compensation, and setting staffing too low at its retail pharmacies, according to the complaint. If found ...

EAST PROVIDENCE, R.I. (WPRI) — A federal lawsuit against CVS Health that was unsealed last month accuses the company of unlawfully filling opioid prescriptions in violation of the Controlled ...

The lawsuit alleges that CVS’s violations stemmed from corporate-mandated performance metrics, incentive compensation and staffing policies that prioritized corporate profits over patient safety.

The complaint alleges that the retail pharmacy filled prescriptions for controlled substances that lacked legitimate medical purpose or were not valid.

CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET to discuss fourth quarter and full year 2024 financial results ...